The Long Run with Luke Timmerman
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
Oct 15, 2024
Chris Garcia, a biochemistry professor at Stanford and biotech entrepreneur, dives into the fascinating world of protein engineering for cancer and autoimmune treatments. He shares his transformative journey from aspiring tennis player to leading immunology research. Topics include the ingenious application of AI in protein design, innovative strategies for enhancing clinical trials, and the significance of T-cell interactions in cancer therapies. Personal anecdotes of endurance running cleverly illustrate how these experiences spark creative breakthroughs in science.
01:03:35
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Chris Garcia highlights the importance of protein engineering in creating novel treatments for cancer and autoimmune diseases.
- His early career shift from tennis to biochemistry underscores the transformative power of life experiences on scientific journeys.
Deep dives
Scientific Background and Achievements
The guest, Kay Christopher Garcia, is a structural immunologist and biochemistry professor at Stanford University, recognized for his pivotal structural discoveries that have transformed the understanding of immune receptors. His research has significant implications for developing new treatments for cancer and autoimmune diseases. He has co-founded several startups such as Synthokine, which focuses on custom-designed cytokine drugs, and ALX Oncology, which explores cancer cells' signals. Garcia’s recent accolades include the Max Cooper Prize in Immunology, highlighting the impact of his pioneering work in the field.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
